S H Kelkar & Co. Q1 FY27 Earnings Call — Analysis (NSE: SHK)
S H Kelkar begins FY27 with 14% revenue growth and 13.4% EBITDA margin, driven by strong flavours performance and stable gross margins, while continuing international expansion investments.
The take
Q1FY27 Revenue ₹662 Cr ( +14% YoY ) . New guidance — FY27 fy27 revenue growth and margins double-digit revenue growth and improved margins . New story: International expansion trajectory .
Results
Revenue ₹662 Cr +14% YoY; EBITDA ₹89 Cr +21% YoY; EBITDA margin 13.4% (+80 bps YoY); net debt ₹852 Cr as of Jun-26.
Financial highlights
| Metric | Value | Change | Basis |
|---|---|---|---|
| Revenue | ₹662 Cr | +14% | yoy · Q1FY27 |
| EBITDA | ₹89 Cr | +21% | yoy · Q1FY27 |
| EBITDA Margin | 13.4% | +80 bps | yoy · Q1FY27 |
| Net Debt | ₹852 Cr | point_in_time · Q1FY27 · as of Jun-26 | |
| Exceptional Income (Insurance) | ₹30 Cr | none · Q1FY27 · fire insurance claim | |
| Flavour Revenue | ₹112 Cr | none · Q1FY27 | |
| Gross Margin | stable YoY | yoy · Q1FY27 |
Guidance
FY27 double-digit revenue growth and improved margins; net debt to stay high until Q3 then decline ~₹25 Cr per quarter; Vanvate factory commissioning in Q3.
What management committed to
- S H Kelkar expects to deliver double-digit revenue growth and improved margins for the full year FY27. — double-digit revenue growth and improved margins, FY27
- Full-year EBITDA margin for FY27, if double-digit revenue growth is sustained, will be similar to or better than Q1FY27's 13.4%. — similar to or better than 13.4%, FY27
- Net debt will remain high until Q2FY27 and then start reducing from Q3FY27, declining by approximately Rs.25 crore quarter-on-quarter thereafter. — reduce ~Rs.25 Cr per quarter, Q3FY27
- Vanvate factory will be commissioned and operational in Q3FY27. — operational in Q3, Q3FY27
- S H Kelkar expects to generate at least USD 1.5-2 million in revenue from the U.S. market in FY27. — $1.5 million to 2 million, FY27
- The German operations are expected to achieve EBITDA breakeven between FY27 and FY28. — EBITDA breakeven, FY28
- Global Ingredients business will see a recovery in the second half of FY27. — H2FY27
- Flavour segment quarterly revenue will exceed Rs.95 Cr in Q2FY27 and improve further in Q3FY27. — Q2 > Rs.95 Cr, Q3 > Q2, Q2FY27
- FY27 effective tax rate will be below 30%. — below 30%, FY27
Key themes
International expansion and operational discipline amid macro caution
How the narrative shifted
- Global macro caution: Management frames geopolitical uncertainty and trade volatility as the primary risk to demand momentum and supply chains, limiting visibility and constraining bold guidance.
- International expansion trajectory: Investments in CDCs and manufacturing in Germany, US, and UK are positioned as the engine for long‐term growth, with a large addressable market ($10 bn) and early revenue traction.
- Strategic inventory for supply security: Management emphasizes deliberate inventory buildup to ensure supply continuity and protect margins against raw material volatility, accepting near-term debt increase as a necessary cost.
- Pricing discipline over volume: The company consciously exited low-margin business and held back sales until price increases were accepted, prioritizing margin quality over headline growth in domestic fragrances.
- Flavour segment outperformance: Flavours delivered exceptional growth, partly aided by preponement, but underlying momentum remains strong; management expects it to continue outperforming other segments.
- Capex cycle nearing completion: Major capex in Europe is complete; Vanvate on track for Q3 commissioning, with only a final India upgradation tranche deferred based on demand, setting the stage for deleveraging.
Operational commentary
- Flavour segment delivered strong broad-based growth with revenue ₹112 Cr; management estimates ~₹15 Cr preponement due to client inventory buildup; normalised quarterly run rate ~₹95-96 Cr, with momentum continuing in July.
- Fragrance India revenue flat YoY due to conscious exit from low-margin business and disciplined pricing; expect normalisation as raw material availability improves.
- Fragrance international: European capex complete, Almere plant operational since May; US expected to generate $1.5-2 mn revenue in FY27; Germany near EBITDA breakeven; UK at early stage.
- Global Ingredients business softer on lower export demand; management watching closely, expects recovery in H2.
- Strategic inventory buildup of extra 45 days to ensure supply security and insulate gross margins from raw material volatility for the next 4-5 months; 95%+ clients accepted price increases.
- Capex: Q1 spent ₹25 Cr in Europe; Q2 expected ₹25 Cr on Vanvate; Vanvate commissioning target Q3; remaining ₹50 Cr India capex (Vashivali upgradation) deployment may occur Q4 or be deferred to FY28.
- Net debt increased ₹65 Cr QoQ to ₹852 Cr due to inventory buildup and capex; management expects deleveraging from Q3 onwards at ~₹25 Cr per quarter.
- Exceptional income of ₹30 Cr recognised toward fire insurance claim; balance Rs.50-60 Cr expected fully settled within FY27.
- R&D investments: additional $3 mn/year in Europe; 10-11% of revenue from products launched in last 3-5 years; new product adoption pipeline healthy.
Analyst Q&A
Q. Can you provide a full-year outlook for the Flavour business given the strong Q1?
Q1 had ~Rs.15 Cr preponement of orders; normalised quarterly run rate is Rs.95-96 Cr, and we expect sequential growth through the year with Q2 likely stronger.
Q. Why was Fragrance India revenue soft, and what are the trends?
Q1 last year was a strong base; we took a conscious decision to exit low-margin business and held back sales to clients until pricing negotiations were complete, prioritising disciplined pricing over volume.
Q. What is the margin outlook for FY27? Should we expect gross margins to sustain?
If double-digit growth is sustained, full-year EBITDA margin should be similar to Q1 or better, with maybe 1% variation; Q1 is a baseline normal quarter, not an exceptional one, but macro uncertainty limits confidence beyond 2-3 months.
Q. What has to be true 3 years from now for the investments in new markets to be considered successful?
We have three new market bets — Germany, USA, UK. Germany should reach EBITDA breakeven between this year and next, USA a year later, and UK a year after that; that trajectory would indicate success.
Research and educational content only. Not investment advice.